X-Vax Technology

Pioneering the future of vaccines to conquer mucosal infections and protect millions globally.

General Information
Company Name
X-Vax Technology
Founded Year
2015
Location (Offices)
Founders / Decision Makers
Ulf Wiinberg - President & CEO Robert Ruffolo - Director Isaac Blech - Vice Chairman Andreas Eggert - Chief Operating Officer Clare Kahn - R&D Strategy Officer
Number of Employees
-
Industries
Biotechnology, Health Care
Funding Stage
Series A
Social Media

X-Vax Technology - Company Profile

X-Vax Technology is a biotechnology company founded in 2015 and based in Jupiter, Florida. The company is dedicated to developing advanced vaccines for mucosal infections including herpes, influenza, tuberculosis, and HIV. With a focus on inducing antibodies to kill infected cells, X-Vax aims to create a more effective immune response to combat these widespread pathogens.

The company's slogan, "Pioneering the future of vaccines to conquer mucosal infections and protect millions globally," encapsulates its mission to address global health concerns.

In July 2019, X-Vax successfully secured a $56.00M Series A investment from a notable group of investors including Founders Fund, Connectivity Ventures Fund, Adjuvant Capital, Alexandria Venture Investments, Helicase Venture, Scientia Ventures, Johnson & Johnson Innovation – JJDC, and Serum Institute of India Pvt. Ltd. This funding is set to propel the company's research and development efforts and expand its potential impact in the field of global healthcare.

Taxonomy: Vaccines, Mucosal Infections, Herpes, Influenza, Tuberculosis, HIV, Antibody Development, Pathogen Vaccines, Infectious Diseases, Immune Response, Preclinical Development, Clinical Development, Florida, Medical Research

Funding Rounds & Investors of X-Vax Technology (2)

View All
Funding Stage Amount No. Investors Investors Date
Series A - X $56.00M 8
Founders Fund, investor in X-Vax Technology's Series A - X round Connectivity Ventures Fund, investor in X-Vax Technology's Series A - X round Adjuvant Capital, investor in X-Vax Technology's Series A - X round Alexandria Venture Investments, investor in X-Vax Technology's Series A - X round Helicase Venture, investor in X-Vax Technology's Series A - X round Scientia Ventures, investor in X-Vax Technology's Series A - X round
Johnson & Johnson Innovation – JJDC, Serum Institute of India Pvt. Ltd. 		23 Jul 2019
Series A - X Unknown 1 Thynk Capital 05 Apr 2019

Latest News of X-Vax Technology

View All

No recent news or press coverage available for X-Vax Technology.

Similar Companies to X-Vax Technology

View All
Aviex Technologies LLC - Similar company to X-Vax Technology
Aviex Technologies LLC Aviex Technologies LLC was founded to develop a novel vaccine platform delivery technology for infectious diseases.
SCG Cell Therapy - Similar company to X-Vax Technology
SCG Cell Therapy Leading the Next Wave of Biotech Breakthroughs
IMMUNITOR Ltd. - Similar company to X-Vax Technology
IMMUNITOR Ltd. Immunitor's proprietary technology enables us to formulate any vaccine as an oral pill.
Light Line Medical, Inc. - Similar company to X-Vax Technology
Light Line Medical, Inc. Light Line has developed a proprietary method of delivering light to prevent and treat catheter associated infections
Evaxion Biotech A/S - Similar company to X-Vax Technology
Evaxion Biotech A/S AI-Immunology™ Powered Vaccines